, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

up 139.62 %

C.r. Bard, Inc. (BCR) rated Outperform with price target $107 by Morgan Keegan

Posted on: Tuesday,  Aug 16, 2011  8:25 AM ET by Morgan Keegan

Morgan Keegan rated Outperform C.r. Bard, Inc. (NYSE: BCR) on 08/16/2011. Previously Morgan Keegan rated Outperform C.r. Bard, Inc. (NYSE: BCR) on
11/18/2009., when the stock price was $82.00. Since then, C.r. Bard, Inc. has gained 139.62% as of 01/20/2016's recent price of $196.49.
If you would have followed the previous Morgan Keegan's recommendation on BCR, you would have gained 139.62% of your investment in 2254 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Since Morgan Keegan's founding 38 years ago, quality investment research has been a hallmark of the firm. Over the years, we have built our reputation by focusing on companies that have gone unnoticed by Wall Street. Today, our staff of senior equity analysts tracks more than 250 companies concentrated in ten industry sectors
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/16/2011 8:25 AM Buy
91.44 107.00
as of 12/30/2011
1 Week up  0.44 %
1 Month down  -1.93 %
3 Months down  -2.33 %
1 YTD down  -6.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/18/2009 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy